David Bom

1.3k total citations
15 papers, 1.1k citations indexed

About

David Bom is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, David Bom has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in David Bom's work include Cancer therapeutics and mechanisms (11 papers), Neutropenia and Cancer Infections (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). David Bom is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Neutropenia and Cancer Infections (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). David Bom collaborates with scholars based in United States. David Bom's co-authors include Dennis P. Curran, Bailin Chen, John E. Anthony, Mark S. Meier, David A. Jacques, Rodney Andrews, John P. Selegue, Thomas G. Burke, Hubert Josien and Sung‐Bo Ko and has published in prestigious journals such as Journal of the American Chemical Society, Nano Letters and Journal of Agricultural and Food Chemistry.

In The Last Decade

David Bom

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Bom United States	12	480	325	262	241	128	15	1.1k
Marcia W. Patchan United States	14	377 0.8×	95 0.3×	161 0.6×	116 0.5×	52 0.4×	25	775
Paulo Almeida Portugal	24	456 0.9×	678 2.1×	468 1.8×	52 0.2×	52 0.4×	103	1.6k
Ateyatallah Aljuhani Saudi Arabia	21	159 0.3×	360 1.1×	669 2.6×	99 0.4×	45 0.4×	49	1.2k
Limin Zhao China	20	310 0.6×	357 1.1×	467 1.8×	75 0.3×	17 0.1×	63	1.3k
Pedro Martins Portugal	9	182 0.4×	176 0.5×	578 2.2×	95 0.4×	30 0.2×	9	926
Zijun Bie China	23	1.1k 2.3×	435 1.3×	177 0.7×	57 0.2×	85 0.7×	33	2.3k
Albert Sun-Chi Chan Hong Kong	16	324 0.7×	227 0.7×	435 1.7×	59 0.2×	22 0.2×	29	1.3k
Jiangnan Zheng China	18	532 1.1×	302 0.9×	146 0.6×	45 0.2×	25 0.2×	38	1.3k
Maciej Serda Poland	17	204 0.4×	243 0.7×	535 2.0×	195 0.8×	35 0.3×	48	990

Countries citing papers authored by David Bom

Since Specialization

Citations

This map shows the geographic impact of David Bom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bom more than expected).

Fields of papers citing papers by David Bom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bom. The network helps show where David Bom may publish in the future.

Co-authorship network of co-authors of David Bom

This figure shows the co-authorship network connecting the top 25 collaborators of David Bom. A scholar is included among the top collaborators of David Bom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bom. David Bom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

McCoy, Mark R., Zheng Yang, Xun Fu, et al.. (2012). Monitoring of Total Type II Pyrethroid Pesticides in Citrus Oils and Water by Converting to a Common Product 3-Phenoxybenzoic Acid. Journal of Agricultural and Food Chemistry. 60(20). 5065–5070. 30 indexed citations

Kruszewski, Stefan, et al.. (2006). Affinity of new anticancer agent, DB-174, to membranes and HSA determined by fluorescence spectroscopy methods. Optica Applicata. 36. 199–207. 2 indexed citations

Tumey, L. Nathan, David Bom, Bayard R. Huck, et al.. (2004). The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(2). 277–281. 70 indexed citations

Liu, Xinli, Bert C. Lynn, Jun Zhang, et al.. (2002). A Versatile Prodrug Approach for Liposomal Core-Loading of Water-Insoluble Camptothecin Anticancer Drugs. Journal of the American Chemical Society. 124(26). 7650–7651. 40 indexed citations

Bom, David, Rodney Andrews, David A. Jacques, et al.. (2002). Thermogravimetric Analysis of the Oxidation of Multiwalled Carbon Nanotubes: Evidence for the Role of Defect Sites in Carbon Nanotube Chemistry. Nano Letters. 2(6). 615–619. 426 indexed citations

Bom, David, et al.. (2001). The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity. Journal of Controlled Release. 74(1-3). 325–333. 47 indexed citations

Curran, Dennis P., Hubert Josien, David Bom, Ana E. Gabarda, & Wu Du. (2000). The Cascade Radical Annulation Approach to New Analogues of Camptothecins: Combinatorial Synthesis of Silatecans and Homosilatecans. Annals of the New York Academy of Sciences. 922(1). 112–121. 17 indexed citations

Du, Wu, Ana E. Gabarda, David Bom, & Dennis P. Curran. (2000). The Combinatorial Synthesis of Racemic Homosilatecan Libraries via a Cascade Radical Annulation. Annals of the New York Academy of Sciences. 922(1). 317–319. 1 indexed citations

Bom, David, Dennis P. Curran, Stefan Kruszewski, et al.. (2000). The Novel Silatecan 7-tert-Butyldimethylsilyl-10-hydroxycamptothecin Displays High Lipophilicity, Improved Human Blood Stability, and Potent Anticancer Activity. Journal of Medicinal Chemistry. 43(21). 3970–3980. 133 indexed citations

10.

Burke, Thomas G. & David Bom. (2000). Campthotecin Design and Delivery Approaches for Elevating Anti‐Topoisomerase I Activities in Vivo. Annals of the New York Academy of Sciences. 922(1). 36–45. 35 indexed citations

11.

Pollack, Ian F., et al.. (1999). Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo.. PubMed. 59(19). 4898–905. 50 indexed citations

12.

Bom, David, Dennis P. Curran, Ashok J. Chavan, et al.. (1999). Novel A,B,E-Ring-Modified Camptothecins Displaying High Lipophilicity and Markedly Improved Human Blood Stabilities. Journal of Medicinal Chemistry. 42(16). 3018–3022. 62 indexed citations

13.

Burke, Thomas G., David Bom, Dennis P. Curran, et al.. (1998). <title>Fluorescence detection of camptothecin anticancer drugs by two-photon excitation</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3259. 136–143. 2 indexed citations

14.

Josien, Hubert, Sung‐Bo Ko, David Bom, & Dennis P. Curran. (1998). A General Synthetic Approach to the (20S)-Camptothecin Family of Antitumor Agents by a Regiocontrolled Cascade Radical Cyclization of Aryl Isonitriles. Chemistry - A European Journal. 4(1). 67–83. 120 indexed citations

15.

Josien, Hubert, et al.. (1997). 7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agents. Bioorganic & Medicinal Chemistry Letters. 7(24). 3189–3194. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact